Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mechanistic insights into xanthine oxidoreductase from development studies of candidate drugs to treat hyperuricemia and gout
Takeshi Nishino, Ken Okamoto
JBIC Journal of Biological Inorganic Chemistry (2014) Vol. 20, Iss. 2, pp. 195-207
Open Access | Times Cited: 91

Showing 1-25 of 91 citing articles:

Review of NAD(P)H-dependent oxidoreductases: Properties, engineering and application
Lara Sellés Vidal, Ciarán L. Kelly, Paweł M. Mordaka, et al.
Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics (2017) Vol. 1866, Iss. 2, pp. 327-347
Open Access | Times Cited: 280
New insights into purine metabolism in metabolic diseases: role of xanthine oxidoreductase activity
Masato Furuhashi
AJP Endocrinology and Metabolism (2020) Vol. 319, Iss. 5, pp. E827-E834
Closed Access | Times Cited: 242
Fatty Acid-Binding Protein 4 in Cardiovascular and Metabolic Diseases
Masato Furuhashi
Journal of Atherosclerosis and Thrombosis (2019) Vol. 26, Iss. 3, pp. 216-232
Open Access | Times Cited: 234
Shortage of Cellular ATP as a Cause of Diseases and Strategies to Enhance ATP
Todd A. Johnson, H. A. Jinnah, Naoyuki Kamatani
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 131
Toward an Understanding of Structural Insights of Xanthine and Aldehyde Oxidases: An Overview of their Inhibitors and Role in Various Diseases
Raj Kumar, Gaurav Joshi, Harveen Kler, et al.
Medicinal Research Reviews (2017) Vol. 38, Iss. 4, pp. 1073-1125
Closed Access | Times Cited: 100
Molecular Mechanisms in Early Diabetic Kidney Disease: Glomerular Endothelial Cell Dysfunction
Emelie Lassén, Ilse S. Daehn
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 24, pp. 9456-9456
Open Access | Times Cited: 96
Purine Metabolism Dysfunctions: Experimental Methods of Detection and Diagnostic Potential
Arrigo F.G. Cicero, Federica Fogacci, Valentina Di Micoli, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7027-7027
Open Access | Times Cited: 41
An updated patent review: xanthine oxidase inhibitors for the treatment of hyperuricemia and gout (2011-2015)
Ritu Ojha, Jagjeet Singh, Anu Ojha, et al.
Expert Opinion on Therapeutic Patents (2016) Vol. 27, Iss. 3, pp. 311-345
Closed Access | Times Cited: 84
Pharmacology and Clinical Drug Candidates in Redox Medicine
Vu Thao-Vi Dao, Ana I. Casas, Ghassan J. Maghzal, et al.
Antioxidants and Redox Signaling (2015) Vol. 23, Iss. 14, pp. 1113-1129
Open Access | Times Cited: 83
Plasma Xanthine Oxidoreductase Activity as a Novel Biomarker of Metabolic Disorders in a General Population
Masato Furuhashi, Megumi Matsumoto, Marenao Tanaka, et al.
Circulation Journal (2018) Vol. 82, Iss. 7, pp. 1892-1899
Open Access | Times Cited: 81
Identification of new drug-like compounds from millets as Xanthine oxidoreductase inhibitors for treatment of Hyperuricemia: A molecular docking and simulation study
Rajesh Kumar Pathak, Ayushi Gupta, Rohit Shukla, et al.
Computational Biology and Chemistry (2018) Vol. 76, pp. 32-41
Closed Access | Times Cited: 72
Computational Characterization of the Inhibition Mechanism of Xanthine Oxidoreductase by Topiroxostat
Yazdan Maghsoud, Chao Dong, G. Andrés Cisneros
ACS Catalysis (2023) Vol. 13, Iss. 9, pp. 6023-6043
Open Access | Times Cited: 19
Differential regulation of hypoxanthine and xanthine by obesity in a general population
Masato Furuhashi, Masayuki Koyama, Yukimura Higashiura, et al.
Journal of Diabetes Investigation (2020) Vol. 11, Iss. 4, pp. 878-887
Open Access | Times Cited: 48
U-shaped relationship between serum uric acid level and decline in renal function during a 10-year period in female subjects: BOREAS-CKD2
Kazuma Mori, Masato Furuhashi, Marenao Tanaka, et al.
Hypertension Research (2020) Vol. 44, Iss. 1, pp. 107-116
Closed Access | Times Cited: 41
Putting xanthine oxidoreductase and aldehyde oxidase on the NO metabolism map: Nitrite reduction by molybdoenzymes
Luísa B. Maia, José J. G. Moura
Redox Biology (2018) Vol. 19, pp. 274-289
Open Access | Times Cited: 46
Independent links between plasma xanthine oxidoreductase activity and levels of adipokines
Masato Furuhashi, Megumi Matsumoto, Takayo Murase, et al.
Journal of Diabetes Investigation (2018) Vol. 10, Iss. 4, pp. 1059-1067
Open Access | Times Cited: 43
The C‐terminal peptide plays a role in the formation of an intermediate form during the transition between xanthine dehydrogenase and xanthine oxidase
Tomoko Nishino, Ken Okamoto, Yuko Kawaguchi, et al.
FEBS Journal (2015) Vol. 282, Iss. 16, pp. 3075-3090
Open Access | Times Cited: 41
Xanthine oxidoreductase inhibition ameliorates high glucose-induced glomerular endothelial injury by activating AMPK through the purine salvage pathway
Keum‐Jin Yang, H. S. Park, Yoon-Kyung Chang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Xanthine oxidoreductase and its inhibitors: relevance for gout
Richard O. Day, Bishoy Kamel, Diluk R. W. Kannangara, et al.
Clinical Science (2016) Vol. 130, Iss. 23, pp. 2167-2180
Closed Access | Times Cited: 36
Investigation of the Inhibition Mechanism of Xanthine Oxidoreductase by Oxipurinol: A Computational Study
Yazdan Maghsoud, Chao Dong, G. Andrés Cisneros
Journal of Chemical Information and Modeling (2023) Vol. 63, Iss. 13, pp. 4190-4206
Open Access | Times Cited: 10
Effects of febuxostat therapy on circulating adipokine profiles in patients with overweight or obesity and asymptomatic hyperuricemia: A randomized controlled study
Meijuan Dong, Zhaohui Cui, Yuanyuan Liu, et al.
Obesity Facts (2024) Vol. 17, Iss. 5, pp. 524-534
Open Access | Times Cited: 3
Xanthine oxidase inhibitory activity of nicotino/isonicotinohydrazides: A systematic approach from in vitro , in silico to in vivo studies
Humaira Zafar, Muhammad Abid Hayat, Sumayya Saied, et al.
Bioorganic & Medicinal Chemistry (2017) Vol. 25, Iss. 8, pp. 2351-2371
Closed Access | Times Cited: 33
Baicalein decreases uric acid and prevents hyperuricemic nephropathy in mice
Xiaolu Meng, Zhuo Mao, Xin Li, et al.
Oncotarget (2017) Vol. 8, Iss. 25, pp. 40305-40317
Open Access | Times Cited: 32
Synthesis, molecular docking and xanthine oxidase inhibitory activity of 5-aryl-1H-tetrazoles
Itrat Fatima, Humaira Zafar, Khalid Mohammed Khan, et al.
Bioorganic Chemistry (2018) Vol. 79, pp. 201-211
Closed Access | Times Cited: 32
Design, synthesis and biological evaluation of N-(4-alkoxy-3-cyanophenyl)isonicotinamide/nicotinamide derivatives as novel xanthine oxidase inhibitors
Tingjian Zhang, Songye Li, Lin Wang, et al.
European Journal of Medicinal Chemistry (2017) Vol. 141, pp. 362-372
Open Access | Times Cited: 30
Page 1 - Next Page

Scroll to top